India to Canada: Ketorolac Export Trade Route

The India to Canada Ketorolac corridor is one of India's established pharmaceutical export routes, with 56 shipments documented worth a combined $3.1M USD. The route is dominated by GLAND PHARMA LTD, which alone accounts for roughly 42% of all export value, reflecting the consolidated nature of India's ketorolac manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $55.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with ketorolac's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 26.7%, placing it at rank #13 among India's top ketorolac export destinations globally.

On the import side, key buyers of Indian ketorolac in Canada include JUNO PHARMACEUTICALS CORP, JUNO PHARMACEUTICALS CORP., JUNO PHARMACEUTICALS CORP and 5 others. JUNO PHARMACEUTICALS CORP is the single largest importer with 30 shipments valued at $1.2M USD.

India's ketorolac exports to Canada are driven primarily by a handful of large-scale manufacturers. GLAND PHARMA LTD with 26 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GLAND PHARMA LTD, GLAND PHARMA LIMITED, GLAND PHARMA LIMITED — together account for 82% of total trade value on this route. The average shipment value of $55.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as ketorolac tromethamine injection 30mg/ml30mg/ml and ketorolac tromethamine injection 30mg ml 30mg ml, suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, JUNO PHARMACEUTICALS CORP is the largest importer with 30 shipments worth $1.2M USD — representing 39% of all ketorolac imports from India on this route. A total of 8 buyers are active on this corridor.